WHO Collaborating Centre for Pharmaceutical Policy and Regulation, Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, David de Wied building, Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands.
World Health Organization (WHO) Regional Office for Europe, UN City, Marmorvej 51, 2100, Copenhagen, Denmark.
BMC Health Serv Res. 2019 Jul 31;19(1):536. doi: 10.1186/s12913-019-4359-8.
Many low- and middle-income countries (LMIC) are moving towards enforcing prescription-only access to antibiotics. This systematic literature review aims to assess the interventions used to enforce existing legislation prohibiting over-the-counter (OTC) sales of antibiotics in LMICs, their impact and examine the methods chosen for impact measurement including their strengths and weaknesses.
Both PubMed and Embase were systematically searched for studies reporting on impact measurement in moving towards prescription only access to antibiotics in LMICs. The PRISMA methodological review framework was used to ensure systematic data collection and analysis of literature. Narrative data synthesis was used due to heterogeneity of study designs.
In total, 15 studies were included that assessed policy impact in 10 different countries. Strategies employed to enforce regulations prohibiting OTC sales of systemic antibiotics included retention of prescriptions for antibiotics by pharmacies, government inspections, engaging pharmacists in the design of interventions, media campaigns for the general public and educational activities for health care workers. A variety of outcomes was used to assess the policy impact; changes in antimicrobial resistance rates, changes in levels of antibiotic use, changes in trends of antibiotic use, changes in OTC supply of antibiotics, and changes in reported practices and knowledge of pharmacists, medicine sellers and the general public. Differences in methodological approaches and outcome assessment made it difficult to compare the effectiveness of law enforcement activities. Most effective appeared to be multifaceted approaches that involved all stakeholders. Monitoring of the impact on total sales of antibiotics by means of an interrupted time series (ITS) analysis and analysis of pharmacies selling antibiotics OTC using mystery clients were the methodologically strongest designs used.
The published literature describing activities to enforce prescription-only access to antibiotics in LMICs is sparse and offers limited guidance. Most likely to be effective are comprehensive multifaceted interventions targeting all stakeholders with regular reinforcement of messages. Policy evaluation should be planned as part of implementation to assess the impact and effectiveness of intervention strategies and to identify targets for further activities. Robust study designs such as ITS analyses and mystery client surveys should be used to monitor policy impact.
许多中低收入国家(LMIC)正在朝着强制规定抗生素只能凭处方购买的方向发展。本系统文献综述旨在评估在 LMIC 国家中实施禁止非处方(OTC)销售抗生素的现有立法所使用的干预措施、其影响,并检查为衡量影响而选择的方法,包括其优缺点。
通过系统检索 PubMed 和 Embase 数据库,检索报告中低收入国家向抗生素凭处方购买过渡过程中影响评估的研究。采用 PRISMA 方法学综述框架,以确保系统地收集和分析文献数据。由于研究设计的异质性,采用叙述性数据综合方法。
共纳入 15 项研究,评估了 10 个不同国家的政策影响。为了执行禁止 OTC 销售全身用抗生素的规定,所采用的策略包括:药剂师保留抗生素处方、政府检查、让药剂师参与干预措施的设计、面向公众的媒体宣传活动以及针对卫生保健工作者的教育活动。评估政策影响使用了各种结果,包括抗菌药物耐药率的变化、抗生素使用水平的变化、抗生素使用趋势的变化、OTC 供应抗生素的变化以及药剂师、药品销售者和公众报告实践和知识的变化。由于方法学方法和结果评估的差异,难以比较执法活动的有效性。最有效的似乎是涉及所有利益攸关方的多方面方法。使用中断时间序列(ITS)分析监测抗生素总销售额的影响,以及使用神秘客户分析销售 OTC 抗生素的药店,是使用的方法学最强的设计。
描述在 LMIC 国家中实施抗生素凭处方购买的文献很少,提供的指导有限。最有效的干预措施可能是针对所有利益攸关方的全面多方面干预措施,定期加强信息传递。应将政策评估作为实施的一部分进行规划,以评估干预策略的影响和有效性,并确定进一步活动的目标。应使用 ITS 分析和神秘客户调查等稳健的研究设计来监测政策影响。